Discovery of Amantamide, a Selective CXCR7 Agonist from Marine Cyanobacteria.

Org Lett

Department of Medicinal Chemistry and Center for Natural Products, Drug Discovery and Development (CNPD3) , University of Florida, Gainesville , Florida 32610 , United States.

Published: March 2019

CXCR7 plays an emerging role in several physiological processes. A linear peptide, amantamide (1), was isolated from marine cyanobacteria, and the structure was determined by NMR and mass spectrometry. The total synthesis was achieved by solid-phase method. After screening two biological target libraries, 1 was identified as a selective CXCR7 agonist. The selective activation of CXCR7 by 1 could provide the basis for developing CXCR7-targeted therapeutics and deciphering the role of CXCR7 in different diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327960PMC
http://dx.doi.org/10.1021/acs.orglett.9b00163DOI Listing

Publication Analysis

Top Keywords

selective cxcr7
8
cxcr7 agonist
8
marine cyanobacteria
8
cxcr7
5
discovery amantamide
4
amantamide selective
4
agonist marine
4
cyanobacteria cxcr7
4
cxcr7 plays
4
plays emerging
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!